Articles

The Role of Automated CE in Optimizing Fermentation-Derived Alternative Proteins

Learn how automated capillary electrophoresis (CE) systems are advancing the analysis of fermentation-derived proteins in the alternative protein industry.
Written byShiama Thiageswaran and Kyle Luttgeharm
Grilled plant-based meat alternatives, representing end products supported by analytical workflows such as automated capillary electrophoresis.

iStock

Register for free to listen to this article
Listen with Speechify
0:00
3:00

The rise of fermentation-derived alternative proteins is reshaping the food innovation landscape. For consumers, they deliver comparable taste, texture, and nutritional value to meat, with lower environmental impact and, in some cases, improved digestibility compared to plant-based protein isolates. Central to this effort is the ability to rigorously characterize the proteins that make up these next-generation products, particularly those produced via precision or biomass fermentation.

As manufacturers aim to replicate the taste, texture, and nutritional value of animal-derived ingredients, analytical workflows must evolve to meet the unique challenges of these novel matrices.

Automated capillary electrophoresis (CE) systems are helping researchers meet the growing analytical demands of fermentation-derived alternative protein development. These systems use an electric field to separate charged molecules through a capillary filled with gel or buffer. Unlike traditional methods, automated CE offers run-to-run consistency and greater tolerance for challenging sample types.

As Kyle Luttgeharm, Product Manager at Agilent Technologies, explains, these systems are particularly effective for analyzing protein expression and purity in samples with complex matrices.

Overcoming Analytical Challenges in Fermentation-Derived Protein Samples

A major hurdle in alternative protein workflows is the complexity of samples derived from fermentation. “The largest challenge is analysis of proteins that come from crude lysates or purified samples that contain high salt buffers,” explains Luttgeharm. These types of matrices can interfere with traditional electrophoresis systems, especially during the separation step. In early-stage lysates, cell debris and mixed biomolecules may obstruct the separation path. In later purification stages, high-salt buffers can destabilize the electric field, affecting protein mobility, distorting band patterns, and ultimately

compromising resolution. These challenges are particularly problematic for systems that do not flush and reset the separation path between runs.

Automated CE addresses these issues with robust sample handling and cleanup between runs. Unlike single-channel separation systems, where separation channels are reused and may contain bends or residues, automated CE systems flush and refill a straight capillary with fresh gel matrix after each run. This ensures consistent separation conditions and improves tolerance for matrix contaminants, making the system well-suited to fermentation-derived samples.

Ensuring Regulatory Readiness Through Automated, Consistent Analysis

The consistency and automation built into CE workflows offer advantages in regulatory and quality assurance contexts. Alternative protein developers pursuing Generally Recognized As Safe (GRAS) status, or aiming to meet transparency and labeling standards, benefit from analytical systems that are both repeatable and software-driven.

“Automated systems generally offer greater control and consistency, removing the human factor present in manual gel-based systems,” Luttgeharm notes.

Moreover, automated CE systems generate digital separation profiles that can be analyzed using peak-picking software, facilitating objective purity assessments. “Regulatory bodies typically prefer systems with automated peak picking over manual methods, such as visually inspecting black-and-white images commonly used in manual systems,” he adds.

This commitment to consistency and data integrity positions Agilent’s ProteoAnalyzer as an essential tool for manufacturers navigating the rigorous regulatory landscape of novel food ingredients. Unlike other automated CE platforms, the ProteoAnalyzer flushes and resets the capillary between runs, enabling reproducible analysis of protein expression and purity even in challenging samples such as crude lysates and high-salt buffers. Its automated peak picking and digital separation profiles further deliver the objective, regulator-preferred assessments needed for compliance.

Supporting Innovation in the Fermentation-Derived Protein Economy

While technical advancements in instrumentation continue, much of the innovation in this space is being driven by the market itself, particularly the push to develop animal-free ingredients with sensory and functional profiles that rival traditional animal products. Fermentation enables scalable production of such proteins, and analytical systems such as automated CE are essential for ensuring product consistency and safety.

By enabling more reliable and streamlined protein analysis, automated CE workflows help alternative protein innovators navigate a landscape shaped by both scientific complexity and regulatory scrutiny. As Luttgeharm concludes, “These systems support the development of high-quality, animal-free proteins that are essential to the future of food.”

Meet the Author(s):

  • Shiama Thiageswaran, assistant editor at SeparatIon Science

    Shiama Thiageswaran is an Assistant Editor at Separation Science. She brings experience in academic publishing and technical writing, and supports the development and editing of scientific content. At Separation Science, she contributes to editorial planning and helps ensure the delivery of clear, accurate, and relevant information for the analytical science community.

    View Full Profile
  • Kyle Luttgeharm, Product Manager with Agilent Technologies

    Dr. Kyle Luttgeharm is a Product Manager with Agilent Technologies. He holds undergraduate degrees in Biology and Biochemistry from Southwestern College in Winfield, Kansas, and a doctorate in Biochemistry from the University of Nebraska-Lincoln. Dr. Luttgeharm previously worked as an Application Scientist with Advanced Analytical Technologies, Inc. and an R&D Scientist with Agilent Technologies. He has extensive experience developing methodologies and assays for Agilent’s parallel capillary electrophoresis technology.

    View Full Profile

Here are some related topics that may interest you:

Loading Next Article...
Loading Next Article...